Carson Leslie Foundation #cureMEdullo Early Career Investigator Award in Medulloblastoma
*The Carson Leslie Foundation #cureMEdullo Early Career Investigator Award in Medulloblastoma deadline has been extended to September 8, 2022
Conquer Cancer, the ASCO Foundation, Carson Leslie Foundation, and #cureMEdullo are collaborating to offer grant funding to early-career investigators who wish to conduct childhood medulloblastoma research.
This is a grant from Carson Leslie Foundation and #cureMEdullo, with Conquer Cancer serving as the lead organization for the review and evaluation of applications and post-award administration.
Brain cancer is the leading cause of cancer death among children, and about 500 children in the United States are diagnosed with medulloblastoma each year. About 20% of childhood brain tumors are medulloblastoma, making it the most common cancerous brain tumor in children but it remains clinically understudied. Thus, there is a need for innovative research and investigators to develop new treatment and care approaches for childhood medulloblastoma patients that would provide fewer long-term side effects including cognitive and physical impairments. The purpose of this award is to attract and retain promising investigators in the field of medulloblastoma by providing critical research funding to early-stage investigators, defined as new investigators who have completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who have not previously competed successfully for substantial NIH research grants (e.g. R01 or equivalent awards). This is a mentored award, and the research project is conducted under the guidance of a scientific mentor.
The total award amount is $100,000 for one year, payable on or about November 1, 2022, and May 1, 2023, in two equal installments. There is funding for one Carson Leslie Foundation #cureMedullo Early Career Investigator Award in Medulloblastoma which will be awarded to the most meritorious application evaluated for this competition.
Applicants must meet the following criteria:
- Hold a Doctoral Degree (PhD, MD, MD/PhD, DO, or equivalent) and within 10 years of obtaining their terminal degrees or post-graduate clinical training (e.g. medical residencies) at the time of grant submission. *PhD applicants who fall outside of the 10-year cutoff are requested to send an email to the Grants team with a copy of their latest CV. Applicants who have questions regarding whether they are at the correct career stage should send an email to the Grants team for clarification and eligibility verification and include their latest CV.
- Be employed at a US-based academic medical and research institution holding a mentored research position (e.g. post-doctoral fellow, clinical research fellow, or equivalent). Current faculty are not eligible for this award.
- Candidates may apply based on a future position provided the institution can confirm their standing. However, positions that are contingent on funding will not be considered eligible.
- Be planning an investigative career in oncology with a focus on childhood medulloblastoma.
- Be working in an oncology research laboratory and is involved in translational or clinical research in medulloblastoma.
- Have a mentor in the medulloblastoma research field from the sponsoring institution. The mentor must assume responsibility and provide guidance for the research.
- Be able to commit at least 60% of full-time effort in research (applies to total research, not just the proposed project) during the award period.
The award does not require US citizenship or permanent residency. However, the proposed research must be conducted in a non-profit research organization, a medical institution or an educational institution located in the United States. The institution is responsible for documenting the applicant’s legal eligibility to work in the US for the duration of the award.
The Medulloblastoma Grants Review Committee reserves the right to evaluate and determine an applicant’s eligibility based on the information and justifications included in the application materials. Applicants who are uncertain about their eligibility are encouraged to contact the Grants team for clarification and provide their CV for evaluation.
The full application must be submitted in accordance with the requirements and instructions of the Request for Proposals (RFP) by the application deadline. A Letter of Intent (LOI) is not required. All application materials must be in English and must be submitted through the Application Portal. Paper applications or applications sent by e-mail or fax will not be accepted. If you have questions, please email the Grants team.
Online Applications Open: May 16, 2022
Full Applications Due: September 8, 2022 (11:59 PM ET)
Anticipated Notification Date: October 2022
Anticipated Award Term: November 1, 2022 – October 30, 2023
Administered through EveryGrant® for
Carson Leslie Foundation and #cureMEdullo